Total Payments
$6,113
2024 Payments
$359.46
Companies
33
Transactions
376
Medicare Patients
4,563
Medicare Billing
$563,398
Payment Breakdown by Category
Food & Beverage$5,951 (97.3%)
Other$124.34 (2.0%)
Education$37.90 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,951 | 364 | 97.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $124.34 | 7 | 2.0% |
| Education | $37.90 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,194 | 78 | $0 (2024) |
| ABBVIE INC. | $927.49 | 57 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $648.45 | 46 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $639.74 | 36 | $0 (2021) |
| Amneal Pharmaceuticals LLC | $415.77 | 25 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $244.75 | 18 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $184.91 | 12 | $0 (2020) |
| UPSHER-SMITH LABORATORIES LLC | $173.05 | 8 | $0 (2021) |
| Lilly USA, LLC | $169.80 | 11 | $0 (2021) |
| Biogen, Inc. | $168.33 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $359.46 | 23 | UCB, Inc. ($140.10) |
| 2023 | $750.98 | 35 | ABBVIE INC. ($436.00) |
| 2022 | $313.39 | 16 | ABBVIE INC. ($282.80) |
| 2021 | $1,502 | 95 | UCB, Inc. ($250.34) |
| 2020 | $1,102 | 66 | UCB, Inc. ($273.23) |
| 2019 | $1,056 | 74 | UCB, Inc. ($331.45) |
| 2018 | $535.69 | 35 | ACADIA Pharmaceuticals Inc ($133.86) |
| 2017 | $493.89 | 32 | ACADIA Pharmaceuticals Inc ($91.24) |
All Payment Transactions
376 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: PAIN | ||||||
| 12/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Neurology | ||||||
| 10/30/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $18.89 | General |
| 10/30/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: Neurology | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: NEUROLOGY | ||||||
| 10/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Neurology | ||||||
| 10/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: Neurology | ||||||
| 09/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.97 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Neurology | ||||||
| 07/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: PAIN | ||||||
| 07/24/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: Neurology | ||||||
| 06/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: PAIN | ||||||
| 05/15/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: NEUROLOGY | ||||||
| 05/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: Neurology | ||||||
| 02/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Neurology | ||||||
| 02/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: Neurology | ||||||
| 02/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Neurology | ||||||
| 02/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: Neurology | ||||||
| 01/31/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.44 | General |
| 01/09/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: Neurology | ||||||
| 12/12/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: Neurology | ||||||
| 12/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,118 | 1,390 | $469,243 | $134,086 |
| 2022 | 10 | 1,107 | 1,413 | $480,199 | $139,541 |
| 2021 | 11 | 1,138 | 1,392 | $426,504 | $139,459 |
| 2020 | 12 | 1,200 | 1,556 | $493,315 | $150,312 |
Total Patients
4,563
Total Services
5,751
Medicare Billing
$563,398
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 300 | $95,694 | $28,067 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 251 | 335 | $75,234 | $21,126 | 28.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 174 | 284 | $71,649 | $20,943 | 29.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 60 | 60 | $55,383 | $17,709 | 32.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 72 | 72 | $40,187 | $11,113 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $39,257 | $10,184 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 68 | 71 | $31,650 | $9,064 | 28.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 63 | 63 | $22,272 | $5,640 | 25.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $19,324 | $5,395 | 27.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 40 | 40 | $18,593 | $4,845 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 239 | 356 | $113,557 | $33,472 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 265 | 370 | $83,095 | $22,986 | 27.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 71 | 71 | $65,537 | $20,623 | 31.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 135 | 217 | $55,308 | $16,920 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 120 | 120 | $49,588 | $13,637 | 27.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 55 | 56 | $31,256 | $8,924 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 53 | 53 | $23,626 | $6,913 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 83 | 83 | $22,912 | $6,304 | 27.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 40 | 41 | $19,058 | $5,271 | 27.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 46 | 46 | $16,262 | $4,491 | 27.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 245 | 327 | $92,922 | $31,170 | 33.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 296 | 383 | $75,214 | $24,835 | 33.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 148 | 228 | $54,020 | $18,570 | 34.4% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 53 | 53 | $46,969 | $15,482 | 33.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 88 | 88 | $36,326 | $10,892 | 30.0% |
About Dr. Andre Hagevik, MD
Dr. Andre Hagevik, MD is a Specialist healthcare provider based in Sun City West, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528039625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andre Hagevik, MD has received a total of $6,113 in payments from pharmaceutical and medical device companies, with $359.46 received in 2024. These payments were reported across 376 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,951).
As a Medicare-enrolled provider, Hagevik has provided services to 4,563 Medicare beneficiaries, totaling 5,751 services with total Medicare billing of $563,398. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Psychiatry, Neurology
- Location Sun City West, AZ
- Active Since 01/28/2006
- Last Updated 03/25/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1528039625
Products in Payments
- Briviact (Drug) $721.06
- NUPLAZID (Drug) $648.45
- RYTARY (Drug) $533.47
- Neupro (Drug) $473.05
- QULIPTA (Drug) $459.70
- UBRELVY (Drug) $456.55
- NURTEC ODT (Drug) $325.37
- AJOVY (Biological) $300.49
- AJOVY (Drug) $272.25
- TROKENDI XR (Drug) $167.09
- EMGALITY (Drug) $149.04
- INBRIJA (Drug) $129.44
- TYSABRI (Biological) $126.11
- ACTHAR (Biological) $112.67
- Aimovig (Biological) $101.96
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $93.56
- XCOPRI (Drug) $81.30
- TOSYMRA (Drug) $79.49
- MIGRANAL (Drug) $72.04
- VYVGART HYTRULO (Drug) $68.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.